Abstract
Toll-like receptors (TLRs) have emerged as critical players in immunity. They are capable of sensing organisms ranging from protozoa to bacteria, fungi or viruses upon detection of the pathogen as well as recognizing endogenous ligands, and triggering transduction pathways. Following activation of the innate immune system, strong inflammatory signals are generated inducing inflammation and activation of the adaptive immune response. However, the deregulation of TLRs signaling pathways may be conducive to the pathogenesis of many infectious diseases. Therefore, innate and adaptive immunity are not simply sequential and complementary mechanisms of resistance to pathogen, they regulate each other through cellular contacts and the secretion of soluble mediators. Herein, we summarize recent findings on TLRs signaling in infectious diseases and how pathogens have developed strategies to evade these pathways. In this context, a potential modulation of the innate immune response could have therapeutic benefit through the development of new drugs as well as vaccination strategies to be employed in infectious diseases.
Keywords: TLR-pathogens interactions, Plasmodium falciparum, lipophosphoglycan, mouse mammary tumor virus (MMTV), Tuberculosis
Current Pharmaceutical Design
Title: Toll-Like Receptors in Human Infectious Diseases
Volume: 12 Issue: 32
Author(s): S. de la Barrera, M. Aleman and M. del C. Sasiain
Affiliation:
Keywords: TLR-pathogens interactions, Plasmodium falciparum, lipophosphoglycan, mouse mammary tumor virus (MMTV), Tuberculosis
Abstract: Toll-like receptors (TLRs) have emerged as critical players in immunity. They are capable of sensing organisms ranging from protozoa to bacteria, fungi or viruses upon detection of the pathogen as well as recognizing endogenous ligands, and triggering transduction pathways. Following activation of the innate immune system, strong inflammatory signals are generated inducing inflammation and activation of the adaptive immune response. However, the deregulation of TLRs signaling pathways may be conducive to the pathogenesis of many infectious diseases. Therefore, innate and adaptive immunity are not simply sequential and complementary mechanisms of resistance to pathogen, they regulate each other through cellular contacts and the secretion of soluble mediators. Herein, we summarize recent findings on TLRs signaling in infectious diseases and how pathogens have developed strategies to evade these pathways. In this context, a potential modulation of the innate immune response could have therapeutic benefit through the development of new drugs as well as vaccination strategies to be employed in infectious diseases.
Export Options
About this article
Cite this article as:
Barrera S. de la, Aleman M. and Sasiain C. M. del, Toll-Like Receptors in Human Infectious Diseases, Current Pharmaceutical Design 2006; 12 (32) . https://dx.doi.org/10.2174/138161206778743493
DOI https://dx.doi.org/10.2174/138161206778743493 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The CD4C/HIVNef Transgenic Model of AIDS
Current HIV Research Venom Peptide Modulators of the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) A Possible Role for Interleukin 37 in the Pathogenesis of Behcet's Disease
Current Molecular Medicine Advancements in Devices and Particle Engineering in Dry Powder Inhalation Technology
Current Topics in Medicinal Chemistry Pyrimidine Salvage Pathway in Mycobacterium tuberculosis
Current Medicinal Chemistry A Review of Molecular Modelling Studies of Dihydrofolate Reductase Inhibitors Against Opportunistic Microorganisms and Comprehensive Evaluation of New Models
Current Pharmaceutical Design Repurposing Drugs to Combat Drug Resistance in Leprosy: A Review of Opportunities
Combinatorial Chemistry & High Throughput Screening The Impact of Infection on the Incidence of Autoimmune Disease
Current Topics in Medicinal Chemistry Prominence of Oxidative Stress in the Management of Anti-tuberculosis Drugs Related Hepatotoxicity
Drug Metabolism Letters An Evolving Role of Piperazine Moieties in Drug Design and Discovery
Mini-Reviews in Medicinal Chemistry Predicting Drugs and Proteins in Parasite Infections with Topological Indices of Complex Networks: Theoretical Backgrounds, Applications and Legal Issues
Current Pharmaceutical Design Predictive In Vitro Models of the Sterilizing Activity of Anti-Tuberculosis Drugs
Current Pharmaceutical Design Targeting the Mannose Receptor with Mannosylated Subunit Vaccines
Current Medicinal Chemistry Molecular Players in Tuberculosis Drug Development: Another Break in the Cell Wall
Current Medicinal Chemistry Cytokines as Immunomodulators in Tuberculosis Therapy
Recent Patents on Anti-Infective Drug Discovery Mutagenicity of N-oxide Containing Heterocycles and Related Compounds: Experimental and Theoretical Studies
Current Topics in Medicinal Chemistry Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis
Current HIV Research Editorial [Hot Topic: Progress in Neglected Disease Drug Discovery (Guest Editors: Andrew L. Hopkins & Paul G. Wyatt)]
Current Topics in Medicinal Chemistry A Brief Review of the Computational Identification of Antifreeze Protein
Current Organic Chemistry State of the Art in African Trypanosome Drug Discovery
Current Topics in Medicinal Chemistry